Summary
ElectroCore Inc (ElectroCore) is a bioelectronic medicine healthcare company. The company engaged in developing vagus nerve stimulation non-invasively (nVNS) therapy for neurology and rheumatology. It primarily focused on headache such as episodic cluster headache, migraine, and posttraumatic headache; rheumatoid arthritis; sjogren's syndrome; exploring acute trauma; chronic central inflammation; and neurodegenerative conditions. ElectroCore’s also involved in treating gastric motility disorders, anxiety, depression, and widespread chronic pain. The company operates in the US. ElectroCore is headquartered in New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ElectroCore Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
- ElectroCore Inc Company Overview
- ElectroCore Inc Company Snapshot
- ElectroCore Inc Pipeline Products and Ongoing Clinical Trials Overview
- ElectroCore Inc – Pipeline Analysis Overview
- ElectroCore Inc - Key Facts
- ElectroCore Inc - Major Products and Services
- ElectroCore Inc Pipeline Products by Development Stage
- ElectroCore Inc Pipeline Products Overview
- GammaCore - Post-Traumatic Headache
- GammaCore - Post-Traumatic Headache Product Overview
- GammaCore - Rheumatoid Arthritis
- GammaCore - Rheumatoid Arthritis Product Overview
- GammaCore - Sjogren’s Syndrome
- GammaCore - Sjogren’s Syndrome Product Overview
- Resolve Stimulator
- Resolve Stimulator Product Overview
- ElectroCore Inc - Key Competitors
- ElectroCore Inc - Key Employees
- ElectroCore Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- ElectroCore Inc, Recent Developments
- Jun 10, 2019: electroCore announces Frank R. Amato to step down as chief executive officer
- May 29, 2019: electroCore announces comprehensive redeployment and cost reduction plan
- May 14, 2019: electroCore reports first quarter 2019 financial results
- May 06, 2019: electroCore selected for Innovation and Technology Payment Program Through NHS England
- May 03, 2019: Real-World Evidence and Insights into gammaCore (nVNS) mechanism of action to be Presented at the American Academy of Neurology’s 71st Annual Meeting
- Mar 27, 2019: electroCore announces fourth quarter and full year 2018 financial results
- Mar 14, 2019: electroCore announces encouraging research supporting key areas of clinical development for its non-invasive vagus nerve stimulator, gammaCore
- Mar 08, 2019: electroCore appointments multiple industry veterans to key management positions
- Feb 26, 2019: electroCore announces positive coverage policies of gammaCore issued by Highmark
- Feb 13, 2019: Stimulating the vagus nerve in the neck might help ease pain associated with PTSD
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- ElectroCore Inc Pipeline Products and Ongoing Clinical Trials Overview
- ElectroCore Inc Pipeline Products by Equipment Type
- ElectroCore Inc Pipeline Products by Indication
- ElectroCore Inc, Key Facts
- ElectroCore Inc, Major Products and Services
- ElectroCore Inc Number of Pipeline Products by Development Stage
- ElectroCore Inc Pipeline Products Summary by Development Stage
- GammaCore - Post-Traumatic Headache - Product Status
- GammaCore - Post-Traumatic Headache - Product Description
- GammaCore - Rheumatoid Arthritis - Product Status
- GammaCore - Rheumatoid Arthritis - Product Description
- GammaCore - Sjogren’s Syndrome - Product Status
- GammaCore - Sjogren’s Syndrome - Product Description
- Resolve Stimulator - Product Status
- Resolve Stimulator - Product Description
- ElectroCore Inc, Key Employees
- Glossary
- List of Figures
- ElectroCore Inc Pipeline Products by Equipment Type
- ElectroCore Inc Pipeline Products by Development Stage